ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $560,000 | -25.8% | 54,615 | +7.6% | 0.00% | -20.0% |
| Q3 2018 | $755,000 | -3.9% | 50,775 | +2.1% | 0.01% | 0.0% |
| Q2 2018 | $786,000 | +25.4% | 49,754 | +0.8% | 0.01% | +25.0% |
| Q1 2018 | $627,000 | -7.7% | 49,351 | -16.8% | 0.00% | -20.0% |
| Q4 2017 | $679,000 | -22.9% | 59,340 | -17.5% | 0.01% | -28.6% |
| Q3 2017 | $881,000 | +175.3% | 71,932 | +157.5% | 0.01% | +133.3% |
| Q2 2017 | $320,000 | -16.7% | 27,936 | +51.5% | 0.00% | 0.0% |
| Q1 2017 | $384,000 | +7.9% | 18,441 | +7.9% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -28.8% | 17,092 | +12.1% | 0.00% | -25.0% |
| Q3 2016 | $500,000 | +24.4% | 15,251 | -3.0% | 0.00% | 0.0% |
| Q2 2016 | $402,000 | – | 15,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |